Cancer Commons News and Events

Cancer Commons Featured by Let’s Win! Pancreatic Cancer

September 22, 2020

A new article published by Lets Win! Pancreatic Cancer highlights our virtual tumor boards, which provide “a highly customized experience, connecting patients with our collaborative network of nurse navigators, PhD scientists, and national experts.” This free service helps people find their best-possible treatment options. The piece features insights from Lola Rahib, PhD, our Director of Scientific and Clinical Affairs, and Shaalan Beg, MD, a member of… Read more »

Cancer Commons Founder Featured by J. The Jewish News of Northern California

September 18, 2020

A new article published in J. The Jewish News of Northern California tells the tale of our founder, Marty Tenenbaum, PhD, and how his own experience with metastatic melanoma inspired him to create Cancer Commons: “Not only did I have a disease which was ‘unsurvivable’ at the time, but then I bet my life on a clinical trial on that disease which failed. That’s enough to give… Read more »

Oncology Nurse Advisor Features Cancer Commons

September 17, 2020

In a new piece for Oncology Nurse Advisor, our Nurse Navigator Leslie Jared, RN, MSN, and Executive Director Erika Vial Monteverdi highlight Cancer Commons as the best place for patients to go “when it seems there is nowhere to turn.” They describe how we help patients and caregivers navigate and explore treatment options for the toughest cancer cases. Leslie and Erika presented the topics covered… Read more »

Cancer Commons Featured by Amazon Web Services

September 2, 2020

In a new guest post on the Amazon Web Services (AWS) Blog, our Executive Director Erika Vial Monteverdi highlights how we apply AWS. Cancer Commons learns from the experiences and outcomes of all patients we serve. This process requires sophisticated computing and analysis of large datasets, and AWS is an integral component of our system: Read the post.

Cancer Commons Featured in World Economic Forum Article

August 6, 2020

“We need to break down the barriers between health institutions to allow patients and their trusted clinicians to access global data about individual patient treatment decisions and outcomes.” … A new article written by lymphoma patient Brad Power outlines why the underlying philosophy that drives our work here at Cancer Commons is so important for ensuring that patients receive the care they need. Brad… Read more »

New Cancer Commons Research Findings Presented at ASCO Virtual Meeting

May 13, 2020

By 2040, we will likely see notable changes in which cancer types are most common and which are most deadly, highlighting the influence of cancer screening programs. Our Director of Scientific and Clinical Affairs, Lola Rahib, PhD, led this research, which was presented at the American Society of Clinical Oncology (ASCO)’s virtual 2020 meeting. These projections, prepared in collaboration with MD Anderson Cancer Center… Read more »

In New STAT Article, Our Founder Shows What COVID-19 Research Can Learn from Cancer

April 30, 2020

Around the world, physicians are seeking better treatments for COVID-19. What can they learn from cancer research? Today, STAT published an article written by Cancer Commons founder Marty Tenenbaum, PhD, in which he outlines how our strategy to learn from cancer patients who are trying treatments beyond the standard of care could also be applied to the coronavirus pandemic: “This same rapid-learning approach can… Read more »

Erika Vial Monteverdi, Executive Director of Cancer Commons

What Sets Cancer Commons Apart?

April 2, 2020

Cancer Commons is a patient-centric, nonprofit network of patients, physicians, and scientists that helps identify the best options for treating an individual’s cancer. Here, our Curious Dr. George asks executive director Erika Vial Monteverdi what sets Cancer Commons apart. Q: As the Executive Director of Cancer Commons, how do you consider our approach to be uniquely different from that of many other organizations working… Read more »

Lola Rahib, PhD (left), and Conan Kinsey, MD, PhD (right), present our findings in San Diego, CA

Cancer Commons Presents New Pancreatic Cancer Research Findings at AACR Conference

January 10, 2020

Today, our Director of Scientific and Clinical Affairs, Lola Rahib, PhD, presented initial findings from our real-world data registry on a novel treatment combination for pancreatic cancer patients. Performed in collaboration with xCures and the University of Utah’s Huntsman Cancer Institute, this research was presented at the Special Conference on Advancing Precision Advancing Precision Medicine Drug Development: Incorporation of Real-World Data and Other Novel Strategies, hosted… Read more »

PMWC Presents a Q&A with Cancer Commons Executive Director

December 6, 2019

In a new Q&A with the Precision Medicine World Conference, Executive Director Erika Vial Monteverdi outlines how Cancer Commons is helping people navigate their treatment, and shares her vision for the future: “We are trying to help advanced cancer patients get practical ‘shots on goal’ against their cancer AND learn from the massive number of therapies tried with patients.” Click here for the full Q&A.… Read more »